In starting a process to impose reciprocal tariffs on American trading partners, the White House is sowing uncertainty and risking inflation.

Trump also didn't commit to pushing Congress to water down a drug pricing programme enacted under President Joe Biden that the pharmaceutical industry has been seeking relief from

As the trade war shows no signs of abating, the U.S. administration is considering expanding tariffs to include automobiles, pharmaceuticals, and chips. President Trump's recent announcement of a potential 25% tariff on these imports has fueled uncertainty,

After promising during his election campaign to put import taxes back at the center of US economic policy, President Donald Trump has moved swiftly in that direction, announcing multiple plans for significant new tariffs aimed at US trading partners.